Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Arthritis & Rheumatism

• Publication date

  2008-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/art.23960PMID 18975314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Duration of illness is an important variable for untreated children with juvenile dermatomyositis.

  2006cited by this paper
• Advances in the treatment of juvenile dermatomyositis

  2006cited by this paper
• The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr.

  2006cited by this paper
• The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids.

  2005cited by this paper
• Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies.

  2004cited by this paper
• Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety.

  2004cited by this paper
• Validation of the Childhood Health Assessment Questionnaire in the Juvenile Idiopathic Myopathies

  2004cited by this paper
• Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops.

  2004cited by this paper
• Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis.

  2003cited by this paper
• Nailfold capillary microscopy in healthy children and in childhood rheumatic diseases: a prospective single blind observational study

  2003cited by this paper
• US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry.

  2003cited by this paper
• Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence.

  2003cited by this paper
• Juvenile dermatomyositis: clinical, laboratorial, histological, therapeutical and evolutive parameters of 35 patients.

  2002cited by this paper
• Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis.

  2002cited by this paper
• Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

  2001cited by this paper
• Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety.

  2000cited by this paper
• Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.

  2000cited by this paper
• Childhood dermatomyositis: clinical course of 36 patients treated with low doses of corticosteroids.

  1998cited by this paper
• Juvenile dermatomyositis: a clinical overview.

  1990cited by this paper
• Raynaud syndrome in childhood.

  1989cited by this paper
• Childhood Dermatomyositis

  1987cited by this paper
• Prognosis in Juvenile Dermatopolymyositis: A Cooperative Retrospective Study of 70 Cases

  1985cited by this paper
• Course of treated juvenile dermatomyositis.

  1984cited by this paper
• Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification.

  1983cited by this paper
• Mortality from polymyositis and dermatomyositis in the United States, 1968-1978.

  1983cited by this paper
• Nailfold capillary abnormalities and clinical outcome in childhood dermatomyositis.

  1982cited by this paper
• Polymyositis and dermatomyositis (second of two parts).

  1975cited by this paper
• Polymyositis and dermatomyositis (first of two parts).

  1975cited by this paper
• Muscles, testing and function

  1971cited by this paper

• Severe Juvenile Dermatomyositis With Peripheral Nervous System Involvement: A Case Report

  2026cites this paper
• Juvenile Dermatomyositis: An Update of the Immunopathogenesis, Clinical Features, and Management

  2026cites this paper
• Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force.

  2025cites this paper
• Tape strip expression profiling of juvenile dermatomyositis skin reveals mitochondrial dysfunction contributing to disease endotype

  2025cites this paper
• Juvenile Dermatomyositis und andere idiopathische inflammatorische Myopathien des Kindesalters

  2024cites this paper
• Childhood Arthritis and Rheumatology Research Alliance Biologic Disease‐Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis

  2024cites this paper
• Personalised medicine in juvenile dermatomyositis: From novel insights in disease mechanisms to changes in clinical practice.

  2024cites this paper
• Evaluation of disease course and major complications in juvenile idiopathic inflammatory myopathy patients

  2024cites this paper
• Predictors of poor outcomes in juvenile dermatomyositis: what do we know? A narrative review.

  2024cites this paper
• Disease activity trajectories in juvenile dermatomyositis from childhood to adulthood.

  2024cites this paper
• Successful treatment with tofacitinib for anti-melanoma differentiation-associated gene 5 antibody-positive juvenile dermatomyositis: case reports and review of the literature

  2024cites this paper
• Connective tissue disease-associated lung disease in children

  2024cites this paper
• Juvenile Dermatomyositis Without Skin Lesions in an Antinuclear Matrix Protein 2 Antibody Seropositive Pediatric Case.

  2023cites this paper
• Fortschritte in der Diagnostik und Therapie der juvenilen Dermatomyositis

  2023cites this paper
• Problems of systemic connective tissue diseases of childhood in historical perspective

  2023cites this paper
• Currently recommended skin scores correlate highly in the assessment of patients with Juvenile Dermatomyositis (JDM)

  2023cites this paper
• Long-standing and poorly controlled disease in juvenile dermatomyositis is associated with calcinosis: a real-world experience from a low-middle income country

  2023cites this paper
• The Clinical, Laboratory, and Imaging Features of Children with Juvenile Dermatomyositis: A Single Center Experience

  2023cites this paper
• Juvenile dermatomyositis. Where are we now?

  2022cites this paper
• Juvenile idiopathic inflammatory myopathies: results of an open single-center retrospective study

  2022cites this paper
• Dermatomyositis und juvenile Dermatomyositis

  2022cites this paper
• The clinical features of juvenile dermatomyositis: A single-centre inception cohort.

  2022cites this paper
• Dermatomiose Juvenil: Relato De Caso

  2022cites this paper
• Characterization of the biomarkers related to the clinical course and outcomes of juvenile dermatomyositis.

  2022cites this paper
• Juvenile Dermatomyositis

  2022cites this paper
• Juvenile dermatomyositis in Thai children: Retrospective review of 30 cases from a tertiary care center.

  2021cites this paper
• Dermatomyositis bei Kindern und Jugendlichen

  2021cites this paper
• Incidence, severity and clinical manifestations of juvenile dermatomyositis among Maori and Pacific Island compared to European children

  2021cites this paper
• Is it time to re-think juvenile-onset Rheumatic and Musculoskeletal Diseases? - First steps towards individualised treatments to meet agreed targets.

  2020cites this paper
• Juvenile Dermatomyositis and the Inflammatory Myopathies

  2020cites this paper
• The polymorphous spectrum of dermatomyositis: classic features, newly described skin lesions, and rare variants

  2020cites this paper
• Corticosteroid discontinuation, complete clinical response and remission in juvenile dermatomyositis.

  2020cites this paper
• Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models

  2020cites this paper
• The Role of Cutaneous Type I IFNs in Autoimmune and Autoinflammatory Diseases

  2020cites this paper
• Comparison of Lesional Juvenile Myositis and Lupus Skin Reveals Overlapping Yet Unique Disease Pathophysiology

  2020cites this paper
• The role of cutaneous type I interferons in autoimmune and autoinflammatory diseases

  2020cites this paper
• Skin Disease is More Recalcitrant Than Muscle Disease: A Long-Term Prospective Study of 184 Children with Juvenile Dermatomyositis.

  2020cites this paper
• Long-term outcomes in Juvenile Myositis patients.

  2020cites this paper
• French expert opinion for the management of juvenile dermatomyositis.

  2019cites this paper
• Modelling disease activity in juvenile dermatomyositis: A Bayesian approach

  2019cites this paper
• Predictive factors for sustained remission with stratification by myositis-specific autoantibodies in adult polymyositis/dermatomyositis.

  2019cites this paper
• Interferon Chemokine Score and Other Cytokine Measures Track With Changes in Disease Activity in Patients With Juvenile and Adult Dermatomyositis

  2019cites this paper
• Physical Fitness in Long-Term Juvenile Dermatomyositis

  2019cites this paper
• Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment

  2019cites this paper
• Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study

  2018cites this paper
• Juvenile Idiopathic Inflammatory Myopathies.

  2018cites this paper
• Intra-Abdominal Appendiceal Abscess Tracking to the Foot: Case Report and Review of the Literature

  2018cites this paper
• Submaximal Exercise Capacity in Juvenile Dermatomyositis after Longterm Disease: The Contribution of Muscle, Lung, and Heart Involvement

  2017cites this paper
• Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease

  2017cites this paper
• State of the art on nailfold capillaroscopy in dermatomyositis and polymyositis.

  2017cites this paper
• Juvenile dermatomyositis: Latest advances.

  2017cites this paper
• Rash and Weakness – A Case of Juvenile Dermatomyositis

  2017cites this paper
• The family impact of caring for a child with juvenile dermatomyositis

  2017cites this paper
• Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms

  2017cites this paper
• Chapter 108 – Pediatric Systemic Lupus Erythematosus, Juvenile Dermatomyositis, Scleroderma, and Vasculitis

  2017cites this paper
• Ocular Manifestations of Pediatric Rheumatic Diseases

  2017cites this paper
• Physiotherapy in Juvenile Dermatomyositis

  2017cites this paper
• Methods for analyzing observational longitudinal prognosis studies for rheumatic diseases: a review & worked example using a clinic-based cohort of juvenile dermatomyositis patients

  2017cites this paper
• Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children

  2017cites this paper
• The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes

  2016cites this paper
• Dermatomyositis: factors predicting relapse

  2016cites this paper
• Consensus-based recommendations for the management of juvenile dermatomyositis

  2016cites this paper
• Chapter 26 – Juvenile Dermatomyositis

  2016cites this paper
• Improving care delivery and outcomes in pediatric rheumatic diseases

  2016cites this paper
• Juvenile Dermatomyositis

  2015influential citation
• Brief Report: Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis

  2015cites this paper
• Quantitative muscle ultrasonography in the follow‐up of juvenile dermatomyositis

  2015cites this paper
• Juvenile dermatomyositis in a Nigerian girl

  2014cites this paper
• NOVI PRISTUP PROCJENI STANJA BOLESTI U DJECE S JUVENILNIM DERMATOMIOZITISOM

  2014cites this paper
• Progress and prognosis in juvenile dermatomyositis

  2014cites this paper
• Correlation of CXCL10, Tumor Necrosis Factor Receptor Type II, and Galectin 9 With Disease Activity in Juvenile Dermatomyositis

  2014cites this paper
• Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study

  2014cites this paper
• Juvenile DermatomyositisKing Hussein Medical Center Experience

  2014cites this paper
• Nailfold capillaroscopy in juvenile rheumatic diseases: known measures, patterns and indications.

  2014cites this paper
• Clinical course and outcomes of Iranian children with juvenile dermatomyositis and polymyositis

  2014cites this paper
• Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool.

  2014cites this paper
• Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.

  2013cites this paper
• The Clinical Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies

  2013cites this paper
• In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity

  2013cites this paper
• Juvenile dermatomyositis at a tertiary care hospital: is there any change in the last decade?

  2013cites this paper
• Clinical features and disease course of patients with juvenile dermatomyositis

  2013cites this paper
• Pediatric Idiopathic Inflammatory Myopathies: An Update on Diagnostic and Treatment Strategies

  2013cites this paper
• Lupus systémique et dermatomyosites de l’enfant

  2013cites this paper
• Lupus sistémico y dermatomiositis infantil

  2013cites this paper
• 108 – Pediatric Systemic Lupus Erythematosus, Dermatomyositis, Scleroderma, and Vasculitis

  2013cites this paper
• Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study

  2012cites this paper
• Möglichkeiten und Grenzen der Kapillarmikroskopie in der Kinderrheumatologie

  2012cites this paper
• Pediatric Systemic Lupus Erythematosus , Dermatomyositis , Scleroderma , and Vasculitis

  2012cites this paper
• An update on the diagnosis and management of juvenile

  2012cites this paper
• The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis

  2012cites this paper
• Actualités de la dermatomyosite juvénile

  2011cites this paper
• Collagen Vascular Disorders

  2011cites this paper
• Chapter 24 – JUVENILE DERMATOMYOSITIS

  2011cites this paper
• Safety and Efficacy of Rituximab in Severe Juvenile Dermatomyositis: Results from 9 Patients from the French Autoimmunity and Rituximab Registry

  2011cites this paper
• Thoracic findings of systemic diseases at high-resolution CT in children.

  2011cites this paper
• Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis.

  2011cites this paper
• Actuality of juvenile dermatomyositis.

  2011cites this paper
• Clinical characteristics and favorable long-term outcomes for patients with idiopathic inflammatory myopathies: a retrospective single center study in China

  2011cites this paper
• Thoracic Findings of Systemic Diseases at High-Resolution CT in

  2011cites this paper
• Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis

  2011cites this paper